Swiss Re AG · SIX:SREN
Swiss Re — Journeys Metabolic — Investor Presentation (October 2023)
12 slides from Swiss Re's investor presentation, October 2023
Slide 1: Allison Hull, DO – Swiss Re October, 2023
Allison Hull, DO Diplomate of the American Board of Internal Medicine and American Board of Pediatrics CMO and Founder, Journeys Metabolic Associate Professor, University of South Florida Swiss Re October, 2023
Slide 2: Clinical Protocol
CLINICAL PROTOCOL ➢ 4- month, evidence-based behavior modification protocol utilizing nutrition as metabolic therapy. ➢ Intentional. Incremental. Multi-disciplinary. ➢ Prescriptive protocol driven by diagnosis, motivators, readiness, and health literacy.
Slide 3: Month 1: The Foundations
Month 1: The Foundations Action Plan Nutrition: Education 3 servings of healthy fats 4 servings of non-starchy vegetables 1-2 servings of fermented foods 100g Net Carbs Carbohydrate modification 64-80 oz of water daily (restrict if applicable) Glucose measurement Self Discovery Habit formation Behav
Slide 4: Month 2: The Journey
Month 2: The Journey Action Plan Nutrition Tracking Education Consume 4 servings of healthy fats Consume 6-8 servings of non-starchy vegetables Consume 1-2 servings of fermented foods Drink 64-80 oz of water daily (restrict if applicable) Mitochondrial health Protein and fat goals identified Fat oxi
Slide 5: Month 3: Endurance Training
Month 3: Endurance Training Action Plan Nutrition Tracking Education Consume 4 servings of healthy fats Consume 6-8 servings of non-starchy vegetables Consume 1-2 servings of fermented foods Drink 64-80 oz of water daily (restrict if applicable) Autophagy Protein and fat goals identified Carbohydrat
Slide 6: Month 4: The Transition From Learning To Living
Month 4: The Transition From Learning To Living Self Reporting (Post Program) Total body weight Blood Pressure Fitness minutes Glucose monitoring (POC blood glucose) Biosense device daily testing (ACE levels) Action Plan Optional Lab values: A1C, Lipid panel, ApoB, AST and ALT, eGFR, Fasting Insulin
Slide 7: Protocol Outcomes Since 2018
PROTOCOL OUTCOMES SINCE 2018 8% 17% 8% 30% Body weight HbA1c SBP Triglyceride reduction* reduction reduction reduction $157 PPPM cost savings $503 PPPM cost savings 5 mmHg reduction Associated with lower with 5-10% reduction (1) with virtual clinics with lowers CV event by risk of vascular events (4
Slide 8: Case Studies
Case Studies Patient: Dave C., 77 yo male (sustained results x 4 years post program) Total Body Weight loss: 80 lbs (25% reduction) HbA1c: 6.8 > 5.0 (26% reduction) Fasting Blood Glucose: 142 > 92 (35% reduction) BP: 148/81 > 110/71 (26% reduction in SBP) NAFLD: Stage 3 > Stage 0 (resolution via US
Slide 9: Case Studies
Case Studies Patient: Catherine S., 58 yo female (sustained results x 2.5 years post program) Total Body Weight loss loss: 41 lbs (19% reduction) Fasting Insulin: 22 > 5 (77 % reduction) HbA1c: 5.8 > 5.2 (10% reduction) Triglycerides: 134 >71 (47% reduction) BP: 131/88 > 114/70 (13% reduction in SBP
Slide 10: Case Studies
Case Studies Patient: James B., 42 yo male (sustained results x 3.5 years post program) Total Body Weight loss: 76 lbs (31% reduction) HDL chol: 38 < 71 (46% increase) Non-HDL chol: 140 >125 (11% reduction) HbA1c: 5.7> 5.2 (9% reduction) Triglycerides: 192 > 66 (65% reduction) BP 147/102 > 122/78 (1
Slide 11: Thank You!
THANK YOU! [email protected] journeysmetabolic.com 813-494-2983 ©
Slide 12: References
REFERENCES 1. Ding Y, Fan X, Blanchette CM, Smolarz BG, Weng W, Ramasamy A. Economic value of nonsurgical weight loss in adults with obesity. J Manag Care Spec Pharm. 2021 Jan;27(1):37-50. doi: 10.18553/jmcp.2020.20036. Epub 2020 Nov 9. PMID: 33164723. 2. Hallberg SJ, McKenzie AL, Williams PT, Bhanp
Journeys Metabolic — Investor Presentation (October 2023) on 6ix